Neogen Corp
General ticker "NEOG" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.8B
Neogen Corp follows the US Stock Market performance with the rate: 2.8%.
Estimated limits based on current volatility of 1.8%: low 11.80$, high 12.24$
Factors to consider:
- US accounted for 51.6% of revenue in the fiscal year ended 2023-05-31
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-05-31 to 2026-05-31
- 2024-05-31 to 2025-05-31 estimated range: [10.29$, 16.58$]
- 2025-05-31 to 2026-05-31 estimated range: [10.39$, 16.61$]
Financial Metrics affecting the NEOG estimates:
- Positive: 0.10 < Non-GAAP EPS, $ of 0.44
- Negative: Operating cash flow per share per price, % of 1.28 <= 2.35
- Positive: 1.03 < Operating profit margin, % of 6.35
- Positive: Interest expense per share, $ of 0.34 <= 0.74
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of -0.21
- Positive: -0.96 < Investing cash flow per share, $ of -0.14
- Negative: Industry operating cash flow per share per price (median), % of -1.64 <= 3.85
- Negative: Inventory ratio change, % of 3.07 > 1.08
Short-term NEOG quotes
Long-term NEOG plot with estimates
Financial data
YTD | 2022-05-31 | 2023-05-31 | 2024-05-31 |
---|---|---|---|
Operating Revenue | $527.16MM | $822.45MM | $924.22MM |
Operating Expenses | $468.54MM | $784.93MM | $865.56MM |
Operating Income | $58.62MM | $37.52MM | $58.66MM |
Non-Operating Income | $1.59MM | $-59.56MM | $-72.97MM |
Interest Expense | $1.27MM | $55.96MM | $73.39MM |
R&D Expense | $17.05MM | $26.04MM | $22.48MM |
Income(Loss) | $60.21MM | $-22.04MM | $-14.30MM |
Taxes | $11.90MM | $0.83MM | $-4.88MM |
Profit(Loss) | $48.31MM | $-22.87MM | $-9.42MM |
Stockholders Equity | $887.37MM | $3,134.22MM | $3,144.14MM |
Inventory | $122.31MM | $133.81MM | $189.27MM |
Assets | $992.93MM | $4,554.43MM | $4,548.83MM |
Operating Cash Flow | $68.04MM | $41.03MM | $35.26MM |
Capital expenditure | $24.43MM | $65.76MM | $111.42MM |
Investing Cash Flow | $-97.23MM | $201.04MM | $-29.31MM |
Financing Cash Flow | $6.81MM | $-118.08MM | $1.92MM |
Earnings Per Share* | $0.45 | $-0.12 | $-0.04 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.